Summary
- Current Price
- As of today, PRAX price is $285.89, down -0.95% in the most recent trading session on
- Current Price All-Time High
- PRAX price is currently -68.73% below its historical high of $914.27 set on
- Market Cap
- PRAX current market cap is $8B, up +87.62% over the past 365 days
- Revenue
- PRAX current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for PRAX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Praxis Precision Medicines, Inc. |
| Ticker | NASDAQ: PRAX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | praxismedicines.com |
| Employees | 116 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $285.89 | |
| Price, 1D Change | -0.95% | |
| Market Cap | $8B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.25 | |
| Revenue | $0.00 | |
| Revenue, 1Y Change | -100.00% | |
| EPS | -$13.48 | |
| EPS, 1Y Change | -31.99% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$13.48 | |
| EPS Estimate | -$14.02 | N/A |
| EPS Est. Change | -4.07% | N/A |
| Revenue | $0.00 | |
| Revenue Estimate | $830.71K | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $285.89 | |
| Price Target | $582.00 | - |
| Price Tgt. Change | +103.57% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$10.10 | -$10.21 | -1.10% | |
| -$13.11 | -$13.48 | -2.80% | |
| -$14.02 | N/A | -4.07% | |
| -$9.49 | N/A | +29.55% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.46M | $8.55M | +487.48% | |
| $239.01K | $0.00 | -100.00% | |
| $830.71K | N/A | - | |
| $345.10M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +42.23% | |
| Price, 3Y | +1,777.77% | |
| Market Cap, 1Y | +87.62% | |
| Market Cap, 3Y | +6,017.67% | |
| Revenue, 1Y | -100.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -31.99% | |
| EPS, 3Y | +80.65% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $285.89 | |
| SMA 200 | $314.90 | |
| SMA 50 | $302.86 | |
| EMA 200 | $286.28 | |
| EMA 50 | $290.22 | |
| MACD | -$6.36 | |
| Beta | 1.25 | |
| ATR | $13.12 | |
| 14-Day RSI | 56.53 | |
| 10-Day Volatility | 61.76% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$13.48 | |
| Gross Profit | -$140.00K | |
| Gross Margin | - | |
| Operating Income | -$326.20M | |
| Operating Margin | - | |
| Net Income | -$303.27M | |
| Net Margin | - | |
| EBITDA | -$326.06M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.00 | |
| 10.22 | ||
| 10.22 | ||
| - | ||
| - | ||
| 77.95 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 5.95 | ||
| -19.11 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $878.14M | |
| $599.33M | ||
| $937.93M | ||
| $610.91M | ||
| $59.79M | ||
| $59.77M | ||
| Total Debt | $110.00K | |
| $110.00K | ||
| $24.63M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $303.27M | ||
| $326.06M | ||
| $140.00K | ||
| $0.00 | ||
| $140.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$249.07M | ||
| -$311.15M | ||
| $702.17M | ||
| Capex | $56.00K | |
| -$249.12M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | ||
| UBS | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Goldman Sachs | → | |
| Wells Fargo | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
No data
Screeners with PRAX
FAQ
- What is the ticker symbol for Praxis Precision Medicines, Inc.?
- The ticker symbol for Praxis Precision Medicines, Inc. is NASDAQ:PRAX
- Does Praxis Precision Medicines, Inc. pay dividends?
- No, Praxis Precision Medicines, Inc. does not pay dividends
- What sector is Praxis Precision Medicines, Inc. in?
- Praxis Precision Medicines, Inc. is in the Healthcare sector
- What industry is Praxis Precision Medicines, Inc. in?
- Praxis Precision Medicines, Inc. is in the Biotechnology industry
- What country is Praxis Precision Medicines, Inc. based in?
- Praxis Precision Medicines, Inc. is headquartered in United States
- When did Praxis Precision Medicines, Inc. go public?
- Praxis Precision Medicines, Inc. initial public offering (IPO) was on October 16, 2020
- Is Praxis Precision Medicines, Inc. in the S&P 500?
- No, Praxis Precision Medicines, Inc. is not included in the S&P 500 index
- Is Praxis Precision Medicines, Inc. in the NASDAQ 100?
- No, Praxis Precision Medicines, Inc. is not included in the NASDAQ 100 index
- Is Praxis Precision Medicines, Inc. in the Dow Jones?
- No, Praxis Precision Medicines, Inc. is not included in the Dow Jones index
- When was Praxis Precision Medicines, Inc. last earnings report?
- Praxis Precision Medicines, Inc.'s most recent earnings report was on August 6, 2026
- When does Praxis Precision Medicines, Inc. report earnings?
- The next expected earnings date for Praxis Precision Medicines, Inc. is November 9, 2026
Data Sources & References
- PRAX Official Website praxismedicines.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1689548/000168954826000029/0001689548-26-000029-index.htm
- PRAX Profile on Yahoo Finance finance.yahoo.com/quote/PRAX
- PRAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/prax
